![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 16, 14336-14342, April 19, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, January 10, 2002
Tyrosine hydroxylase (TH), the
initial and rate-limiting enzyme in the biosynthesis of the
neurotransmitter dopamine, is inactivated by peroxynitrite. The sites
of peroxynitrite-induced tyrosine nitration in TH have been identified
by matrix-assisted laser desorption time-of-flight mass spectrometry
and tyrosine-scanning mutagenesis. V8 proteolytic fragments of nitrated
TH were analyzed by matrix-assisted laser desorption time-of-flight
mass spectrometry. A peptide of 3135.4 daltons, corresponding to
residues V410-E436 of TH, showed peroxynitrite-induced mass shifts of
+45, +90, and +135 daltons, reflecting nitration of one, two, or three
tyrosines, respectively. These modifications were not evident in
untreated TH. The tyrosine residues (positions 423, 428, and 432)
within this peptide were mutated to phenylalanine to confirm the
site(s) of nitration and assess the effects of mutation on TH activity. Single mutants expressed wild-type levels of TH catalytic activity and
were inactivated by peroxynitrite while showing reduced (30-60%) levels of nitration. The double mutants Y423F,Y428F, Y423F,Y432F, and
Y428F,Y432F showed trace amounts of tyrosine nitration (7-30% of
control) after exposure to peroxynitrite, and the triple mutant Y423F,Y428F,Y432F was not a substrate for nitration, yet peroxynitrite significantly reduced the activity of each. When all tyrosine mutants
were probed with PEO-maleimide activated biotin, a
thiol-reactive reagent that specifically labels reduced cysteine
residues in proteins, it was evident that peroxynitrite resulted in
cysteine oxidation. These studies identify residues
Tyr423, Tyr428, and
Tyr432 as the sites of peroxynitrite-induced nitration in
TH. No single tyrosine residue appears to be critical for TH catalytic
function, and tyrosine nitration is neither necessary nor sufficient
for peroxynitrite-induced inactivation. The loss of TH catalytic
activity caused by peroxynitrite is associated instead with oxidation
of cysteine residues.
Tyrosine hydroxylase
(TH)1 is the initial and
rate-limiting enzyme in the biosynthesis of the neurotransmitter
dopamine. TH is inhibited by the dopamine neurotoxin
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in PC12 cells and in mice
after in vivo treatment (1), suggesting that losses in TH
activity that are seen in this model of Parkinson's disease may occur
early in the process of dopamine neuronal degeneration. The mechanisms
by which 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine damages dopamine
neurons are complex and are thought to involve, at least in part, the
production of peroxynitrite (ONOO Ischiropoulos and colleagues (1) first concluded that
Tyr225 was the site in TH of ONOO ONOO Based on the importance of TH to dopamine neuronal function, and
considering the possibility that ONOO Materials--
Diethylenetriamine pentaacetic acid,
5,5'-dithiobis-2-nitrobenzoic acid (DTNB),
p-chloromercuribenzoic acid (pCMB),
Me2SO, glutathione, bradykinin, bovine pancreatic
insulin, and Preparation of TH, Site-directed Mutagenesis, and Treatment with
ONOO MALDI-TOF Mass Spectrometry--
TH and
ONOO Analysis of ONOO Analysis of TH Sulfhydryl Status after ONOO Treatment of TH with Sulfhydryl-selective
Reagents--
Wild-type TH (10 µM) was treated at
30 °C for 15 min with varying concentrations of the selective
sulfhydryl reagents pCMB or DTNB as described above for
ONOO MALDI-TOF Mass Spectrometry of ONOO
The inset to Fig. 1 is an abbreviated segment of a better
quality mass spectrum of only the triply nitrated species. To obtain the sample for this spectrum, another sample of
ONOO Site-directed Mutagenesis of Tyrosines 423, 428, and 432--
Each
tyrosine residue within the 3135.4-Da peptide of TH was mutated to
phenylalanine, and the effect of ONOO Tyrosine-scanning Mutagenesis of TH--
Each of the remaining 14 tyrosines in TH, not described above for Fig. 2, was converted to
phenylalanine individually, and the effects of ONOO Effects of ONOO Effects of Selective Sulfhydryl Reagents on TH
Activity--
Various sulfhydryl reagents that are highly specific in
their reactivity with cysteines and that have no reactivity with
tyrosine residues (31) were tested for their effects on TH activity and cysteine status of the enzyme. In view of the data of Fig. 3, showing
that Tyr423, Tyr428, and Tyr432
mutants did not differ from wild-type TH in the extent to which ONOO TH is the initial and rate-limiting enzyme in dopamine
biosynthesis, and, as such, alterations in its activity will have
corresponding effects on the availability of dopamine for release into
synaptic activity. TH is inhibited by
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in vivo through
a process that is thought to involve ONOO Identification of the sites in TH that are modified by
ONOO Analysis of V8 protease-cleaved nitrated TH by MALDI-TOF MS identified
a fragment having a [M + H]+ molecular mass of 3135.4 Da,
corresponding to amino acid residues Val410-Glu436. The mass spectrum also shows
three less intense peaks that were shifted +45, +90, and +135 units
from the major peak, corresponding to nitration of one, two, or three
tyrosines, respectively, within this V8 protease-cleaved TH peptide.
These peaks were not observed in the mass spectrum of untreated TH.
Additional confirmation of these multiple nitrations can be drawn from
the appearance of peaks 16 and 32 units lower than those representing
nitration. These correspond to products from prompt fragmentation
caused by the immediate loss of an oxygen from a nitro group to form a
nitroso species, followed by a second loss of oxygen to probably either
a nitrene or dehydroazepine species (30). To confirm MALDI-TOF findings
and assess the impact of nitration of these residues on TH activity,
tyrosines 423, 428, and 432 were mutated to phenylalanine individually
and in all possible combinations of double and triple substitutions.
This approach revealed several interesting results with regard to
tyrosine nitration of the enzyme. First, ONOO The conservative substitution of tyrosines 423, 428, and 432 with
phenylalanine had only minor impact on TH activity in the single and
double mutants. Y423F and Y428F expressed wild-type levels of TH
activity, and the activity Y432F was ~20% lower than wild-type.
Y423/428F, Y423/432F, and Y428/432F expressed basal levels of activity
that ranged from 60 to 80% of wild type. The differences in activity
between the latter two double mutants and wild-type TH were
statistically significant. The triple mutant expressed much lower
levels of TH enzyme activity (~20% of wild type) by comparison with
all other forms of the enzyme. Regardless of the basal levels of
activity, all tyrosine mutants of TH were inhibited by
ONOO The observation that ONOO Tyrosine-scanning mutagenesis of TH does not single out any particular
tyrosine residue as being absolutely essential for TH catalytic
function. Furthermore, it does not appear that tyrosine residues play a
significant role in TH catalysis. Our results agree well with those of
Daubner et al. (35), who showed that mutation of
Tyr371 to phenylalanine did not disrupt TH catalytic
function. Similarly, a Y325F mutant of phenylalanine hydroxylase has
normal levels of activity (36). Tyr325 in phenylalanine
hydroxylase corresponds to Tyr371 in TH. Tyr371
is near the catalytic site of TH (37), where it is in one of four
The present results have identified Tyr423,
Tyr428, and Tyr432 in TH as the sites of
nitration by ONOO *
This work was supported by National Institute on Drug Abuse
Grant DA 10756, the Joe Young, Sr. Psychiatric Research Fund of the
Department of Psychiatry and Behavioral Neurosciences, and a Veterans
Affairs Merit Award.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, February 7, 2002, DOI 10.1074/jbc.M200290200
The abbreviations used are:
TH, tyrosine
hydroxylase;
ONOO
Peroxynitrite-induced Nitration of Tyrosine Hydroxylase
IDENTIFICATION OF TYROSINES 423, 428, AND 432 AS SITES OF
MODIFICATION BY MATRIX-ASSISTED LASER DESORPTION IONIZATION
TIME-OF-FLIGHT MASS SPECTROMETRY AND TYROSINE-SCANNING MUTAGENESIS*
§¶
,
,
,
,
¶,
Department of Psychiatry and Behavioral
Neurosciences, § Center for Molecular Medicine and Genetics,
Wayne State University School of Medicine, and ¶ John D. Dingell
Veterans Affairs Medical Center, Detroit, Michigan 48201 and the
** Department of Biochemistry, Michigan State University,
East Lansing, Michigan 48824
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
) (2). TH is inhibited
by ONOO
in vitro (1, 3) and in PC12 cells (4).
The ONOO
-induced inhibition of TH is associated with
nitration of tyrosine residues (1) and oxidation of cysteine residues
(3), yet neither the identity of the modified residues in TH nor the
relative contribution of these posttranslational modifications to loss of catalytic function is known.
-induced
nitration and attributed enzyme inhibition to this posttranslational modification. A more recent paper from the same group purports that
Tyr423, not Tyr225, is the actual site
mediating enzyme inactivation after nitration by ONOO
(5). A Y423F mutant of TH was extensively nitrated by high concentrations of ONOO
, but its catalytic activity was
not inhibited (5).
is a powerful oxidant that can modify cysteine,
tryptophan, methionine, and tyrosine residues in proteins. It can also cause lipid peroxidation and DNA damage and lead to mitochondrial dysfunction, effects that contribute to its cytotoxic potential (6-10). Indeed, the ONOO
-induced nitration of free
tyrosine or of tyrosine residues in proteins is used increasingly as a
molecular marker of ONOO
participation in conditions that
are associated with cell damage or disease states (11-15). Increased
tyrosine nitration of proteins, including the Lewy body constituent
-synuclein (16-18), in post-mortem tissue from individuals with
Parkinson's disease (19, 20) suggests that ONOO
-induced
tyrosine nitration plays a causative role in dopamine neuronal
degeneration and in TH dysfunction.
causes the
inhibition of TH as an early event in the process of dopamine neuronal
degeneration (1, 5), we sought to determine the sites at which TH is
modified by ONOO
. MALDI-TOF mass spectrometry and
tyrosine-scanning mutagenesis have identified tyrosines 423, 428, and
432 as the sites of ONOO
-induced nitration.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-cyano-4-hydroxycinnamic acid and glutathione-agarose
were obtained from Sigma. Catalase and a monoclonal antibody against TH
were products of Boehringer Mannheim. Thrombin and pGEX vectors were
obtained from Amersham Biosciences. Protease V8 was purchased from
Promega (Madison, WI). Guanidine hydrochloride was from Invitrogen
(Carlsbad, CA). Tetrahydrobiopterin was purchased from Dr. Shircks
Laboratories (Jona, Switzerland). A monoclonal antibody against
nitrotyrosine was purchased from Cayman Chemical Company (Ann Arbor,
MI), and horseradish peroxidase-linked goat anti-mouse IgGs were
products of Cappel. Trypsin, PEO-maleimide-activated biotin (PMAB), and Immunopure TMB peroxidase kits were obtained from Pierce.
N-biotinoyl-N-(iodoacetyl)ethylene diamine (BIAM)
was purchased from Molecular Probes, Inc. (Eugene, OR). Enhanced
chemiluminescence reagents were products of PerkinElmer Life Sciences,
and Bio-Max MR film was from Eastman Kodak Co. Restriction
endonucleases, T4 ligase, and T4 kinase were products of New England
Biolabs. Acetonitrile and trifluoroacetic acid were HPLC grade,
and all other reagents were obtained from commercial sources in the
highest possible qualities.
--
TH was cloned by reverse
transcriptase-polymerase chain reaction and expressed as a glutathione
S-transferase fusion protein as previously described (3,
21). Tyr-to-Phe site-directed mutagenesis of TH was carried out for
each of its 17 tyrosine residues (22) via splicing by overlap extension
(23). For selected tyrosine residues (see below), double and triple
tyrosine mutants were also created. Automated nucleotide sequencing
confirmed all mutations. Recombinant fusion proteins were purified by
glutathione-agarose affinity chromatography, and the glutathione
S-transferase fusion tag was removed by thrombin cleavage,
resulting in highly purified TH preparations (>95% pure).
ONOO
was synthesized by the quenched-flow method of
Beckman et al. (24), and its concentration was
determined by the extinction coefficient
302 = 1670 M
1 cm
1. The hydrogen peroxide
contamination of ONOO
solutions was removed by manganese
dioxide chromatography and filtration (24). ONOO
(100-500 µM) was added to TH (10 µM with
respect to the 60-kDa monomer) with vigorous mixing in 50 mM potassium phosphate buffer, pH 7.4, containing 100 µM diethylenetriamine pentaacetic acid, and incubations
were carried out for 15 min at 30°C. The volume of ONOO
added to the enzyme samples was always less than 1% (v/v) and did not
influence pH. Upon completion of incubation with ONOO
,
samples were diluted 1:10 with 50 mM potassium phosphate,
pH 6, and stored at 4°C. Residual TH activity was assayed according to the method of Lerner et al. (25). Protein concentrations were determined as described by Bradford (26).
-treated TH (TH-ONOO
) were individually
purified by reversed-phase HPLC. The HPLC system consisted of two
Waters 6000 pumps (controlled by a personal computer) in line with a Spectroflow 757 UV detector set at 214 nm. A gradient of
20-65% acetonitrile in 0.1% trifluoroacetic acid was
applied in a 60-min time period over a Vydac C18 (4.6 × 250 mm,
5-µm particle size, 300-Å pores) column. Fractions corresponding to
the whole protein were collected and dried in a vacuum system. Seventy
micrograms of TH and 70 µg of TH-ONOO
were individually
reconstituted in 60 µl of 6 M guanidine hydrochloride in
50 mM Trizma hydrochloride buffer, pH 8.0. To this was
added 330 µl of water and 330 µl of 1 mM
CaCl2 in 50 mM Trizma hydrochloride, pH 7.6. Three micrograms of protease V8 (in 3 µl) was added to each sample,
which was mixed and allowed to sit for 18 h at room temperature.
Samples were then evaporated under vacuum to ~200 µl followed by
the addition of 1.6 µl of trifluoroacetic acid. Next, they were
purified by C18 ZipTip (Millipore Corp., Bedford, MA) application and
eluted into 5 µl of 0.1% trifluoroacetic acid/acetonitrile (1:1)
saturated with
-cyano-4-hydroxycinnamic acid. One microliter was
then spotted onto a gold-plated MALDI plate to which had been applied
an ultrathin layer of
-cyano-4-hydroxycinnamic acid according to the
method of Cadene and Chait (27). To obtain better MALDI-TOF MS ion
counting statistics for the triply nitrated species, 40 µg of the V8
digest was separated by microbore HPLC, and fractions were collected
corresponding to the nitrated species. Microbore HPLC conditions were
as follows. Flow rate was set at 0.05 ml/min across a 150 × 1.0-mm column with the same sorbent as above. Solvent A was 0.1%
trifluoroacetic acid in water containing 10 mM EDTA-free acid. Solvent B was 0.1% trifluoroacetic acid in 98:2
acetonitrile/water containing 10 mM EDTA free acid. A
gradient of 0% B to 45% B was applied linearly over 60 min. The
fraction corresponding to the triply nitrated species was dried under a
vacuum and reconstituted in 1 µl of the above matrix solution, and
0.5 µl was spotted onto a MALDI plate. MALDI mass spectra were
acquired on a Voyager DE-STR TOF mass spectrometer (PerkinElmer Life
Sciences) equipped with a 337-nm nitrogen laser. In linear mode, the
accelerating voltage was set to 20,000 V with grid voltage at 95%,
guide wire turned off, and extraction delay time at 400 ns. In
reflector mode, the accelerating voltage was set to 20,000 V with grid
voltage at 76%, mirror voltage ratio at 1.12, guide wire at 0.05%,
and extraction delay time at 310 ns. Time of flight to mass conversion
was achieved with the use of external standards of bradykinin
(monoisotopic calculated mass for [M + H]+ = 1060.57 Da;
average mass for [M + H]+ = 1061.22 Da) and bovine
pancreatic insulin (average calculated mass for [M + H]+ = 5734.56 Da; average calculated mass for [M + 2H]2+ = 2867.78 Da).
-induced Tyrosine
Nitration--
Following treatment with ONOO
, wild type
TH and all Tyr-to-Phe mutants were analyzed for nitrotyrosine content
by ELISA and Western blotting. ELISA was used in initial screens of TH
tyrosine nitration because of its sensitivity and high sample
throughput capability. Once Tyr-to-Phe mutants were identified that
were reduced in the extent to which they were tyrosine-nitrated by ONOO
, these mutants were analyzed by Western blotting as
well. ELISA assays were optimized to determine nitrotyrosine
immunoreactivity in TH preparations. Control and
ONOO
-treated TH samples containing 200 ng of protein were
adsorbed overnight at 4 °C to 96-well Nunc-Immuno plates with
Maxi-Sorp surfaces. Sample wells were washed three times with
phosphate-buffered saline and then blocked with nonfat dry milk (5%
w/v) for 2 h at room temperature. Plates were incubated overnight
at 4 °C with a monoclonal antibody against nitrotyrosine (1:1000
dilution in nonfat dry milk). Following three washes with
phosphate-buffered saline, wells were incubated with a horseradish
peroxidase-coupled goat anti-mouse secondary antibody (1:10,000
dilution in nonfat dried milk) at room temperature for 2 h.
Immunopure TMB peroxidase substrate was added to wells, and
absorbance was read in a microtiter plate reader at 550 nm. Under these
conditions, absorbance readings for nitrotyrosine immunoreactivity in
TH were linear up to 500 ng of protein/well. All samples were applied
to plates in triplicate. Untreated wild-type TH and
ONOO
-nitrated TH samples were applied to wells throughout
the plate as internal controls. For Western blotting, TH preparations
were subjected to SDS-polyacrylamide gel electrophoresis on 10% gels according to Laemmli (28). Proteins were transferred to nitrocellulose, blocked in Tris-buffered saline containing Tween 20 (0.1% v/v) and 5%
nonfat dry milk and probed with a monoclonal antibody specific for
nitrotyrosine. After incubations with primary antibodies (diluted 1:2000), blots were incubated with goat anti-mouse secondary antibody conjugated with horseradish peroxidase (diluted 1:5000), and
immunoreactive protein bands were visualized with enhanced
chemiluminescence by exposure to Kodak Biomax MR film. Digital images
of films were captured with a Sony CCD-IRIS/RGB color video camera, and
relative pixel densities of protein bands were obtained.
Treatment--
The effect of ONOO
on TH sulfhydryls was
determined with the use of thiol-reactive biotinylation reagents as
described by Kim et al. (29). PMAB and BIAM react
selectively with reduced cysteines in proteins and do not react with
cysteines that have been oxidized (29). These probes are not
quantitative, but they allow a relative measure of the extent to which
cysteine residues have been oxidized. Initial screening of the effects
of ONOO
on the status of sulfhydryls in TH (wild-type and
all mutants) was carried out with ELISA as described above for the
determination of nitrotyrosine content of TH. Untreated or
ONOO
-treated TH was diluted 1:2 with 100 mM
Tris-HCl, pH 6.5 or pH 8.5, for subsequent labeling with PMAB (50 µM) or BIAM (50 µM), respectively. Proteins
were labeled for 60 min at room temperature in the dark, after which
they were subjected to SDS-PAGE and blotting to nitrocellulose.
Remaining samples were diluted 1:50 with phosphate-buffered saline, and
50 ng of protein was applied to 96-well plates. Blots and plates were
then processed as described above with the exception that horseradish
peroxidase-linked avidin (diluted 1:500 in nonfat dry milk) was used in
place of a secondary antibody, and biotin reactivity was visualized by
ECL. Absorbance readings for the biotinylated labels on 96-well plates
were linear up to 200 ng per well.
. Following treatment, TH samples were diluted 1:10
with 50 mM potassium phosphate, pH 6. Residual TH activity
was assayed, or samples were probed with PMAB as described above.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-treated
TH--
The V8 partial cleavage fragment containing amino acid
residues 410-436 (VRAFDPDTAAVQPYQDQTYQPVYFVSE) was obtained in good yield and used to determine the nitration status of tyrosine residues 423, 428, and 432 after treatment of intact TH with ONOO
.
The calculated average mass for [M + H]+ of the native
peptide is 3136.40 Da; the observed peak at m/z 3136.0 in linear mode and at m/z 3136.46 in
reflector mode represented the protonated species. Treatment of TH with
ONOO
produced four congeners of the protein consisting of
0-3 nitration events per molecule, with each nitro group adding 45 Da
to the V8 fragment. Thus, peaks at m/z 3181.48, m/z 3226.88, and m/z 3271.85 (Fig. 1) correspond to one, two,
and three nitration events per protein molecule, respectively. Peaks
occurring 16 and 32 units lower than those representing nitration
correspond to products from prompt fragmentation caused by the
immediate loss of an oxygen from a nitro group to form a nitroso
species, followed by loss of a second oxygen possibly to form a nitrene
or dehydroazepine species as outlined by Sarver et al. (30).
Untreated TH did not produce any peaks in the m/z
range corresponding to the nitrated peptides (data not shown). Two
additional, unrelated peaks are present in the mass spectra of both the
ONOO
-treated and untreated samples. The peak at
m/z 3289 corresponds to V8 partial cleavage
fragment Leu333-Glu363. The peak at
m/z 3307 is unidentified but is not related to
ONOO
treatment, since it is also present in the mass
spectrum of the analogous V8 digestion fragment of untreated TH.

View larger version (23K):
[in a new window]
Fig. 1.
Reflectron positive ion MALDI-TOF MS spectrum
of a V8 proteolytic digest of TH. TH was nitrated with
ONOO
as described under "Experimental
Procedures" and subjected to V8 proteolytic digestion.
Analysis of the unseparated digest mixture by MALDI-TOF MS yielded an
ion of m/z of 3136.41, representing amino acid
residues Val410-Glu436 of TH. This proteolytic
fragment of TH contains residues Tyr423,
Tyr428, and Tyr432. Peaks at
m/z values of 3181.48, 3226.88, and 3271.85 in
the mass spectrum correspond to derivatives of this proteolytic
fragment by nitration of one, two, or three tyrosine residues. Peaks
corresponding to photodecomposition product ions 16 and 32 units lower
than the peak for the nitrated species were also observed, representing
products from prompt fragmentation caused by the immediate loss of an
oxygen from a nitro group to form a nitroso species, followed by loss
of a second oxygen possibly forming either a nitrene or dehydroazepine
species. The inset shows a MALDI-TOF mass spectrum of an
HPLC fraction containing the V8 proteolytic fragment of interest, more
clearly showing the triply nitrated species at
m/z 3271.4. Peaks 16-unit multiples lower than
that of the triply nitrated species represent prompt fragmentation
peaks as described for the mass spectrum in the primary
figure. None of these peaks indicative of nitration was
apparent in the mass spectrum of V8 proteolytic digests of untreated
TH.
-treated TH was digested by V8, and the mixture was
separated by HPLC, which allowed the differently nitrated peptides to
be isolated and analyzed by MALDI-TOF. The peak at
m/z 3271.4 in the inset mass spectrum
in Fig. 1 corresponds to the triply nitrated species as shown in Fig.
1. Prompt fragmentation peaks are also seen in the inset at
16-unit multiples lower than the m/z 3271.4 peak
(e.g. at m/z 3255.4 and 3239.8). The
prompt fragmentation peaks appear larger for the triply nitrated
species than for the doubly or singly nitrated species, because all
three nitro groups in the triply nitrated species can undergo
photodecomposition, leading to greater accumulation of lower mass
species (i.e. increments of 16 Da).
on tyrosine
nitration and enzyme activity expressed by these mutants was
determined. Tyr225 was also mutated, because it was
previously claimed to be the site of ONOO
-induced
nitration (1). Fig. 2A
presents results with ONOO
-induced nitration of Y423F,
Y428F, and Y432F as assessed by anti-nitrotyrosine immunoreactivity.
The extent to which ONOO
caused nitration in these
mutants was reduced by comparison with wild-type TH. Digital scans of
the data in Fig. 2A indicated that Y423F nitration was
reduced to 27% of control when normalized to the amount of TH protein
in each sample (see Fig. 2B). Similarly, the nitration of
Y428F and Y432F was reduced to 32 and 39% of control, respectively.
All possible combinations of double tyrosine mutants were made among
these tyrosines, and the ONOO
-induced nitration of these
mutants is shown in Fig. 2A as well. It can be seen that
nitration of Y423F/Y432F (6% of control), Y428F,Y432F (16% of
control), and Y423F,Y428F (27% of control) was reduced more than seen
with the single mutants. Finally, the triple tyrosine mutant
Y423F,Y428F,Y432F was not nitrated by ONOO
(last lane of Fig. 2A). The removal of
Tyr225 from TH resulted in a 20% increase in tyrosine
nitration after ONOO
treatment. The effects of tyrosine
mutagenesis on basal TH activity and on the extent to which
ONOO
modified catalytic activity of the mutants are
presented in Fig. 2C. Single or double mutations of
Tyr423, Tyr428, and Tyr432 to
phenylalanine were tolerated very well by the enzyme. All expressed
levels of activity that were within 20% of wild-type TH, with the
exceptions of Y423F,Y432F and Y428F,Y432F, whose basal levels of
activity were 60 and 69% of wild type, respectively. The triple
Y423F,Y428F,Y432F mutant showed somewhat more disruption of catalytic
function, expressing basal levels of activity that were ~20% of
control. Fig. 2C also shows that ONOO
(100 µM) reduced the catalytic activity of wild type TH and
each mutant, regardless of basal levels of activity. The effect of ONOO
on Y423F and Y428F was the same as its effect on
wild-type enzyme, but the remaining mutants appeared to be more
sensitive to inhibition. For example, ONOO
reduced the
activity of Y432F to 20% of control, and the double mutants were
inhibited by 80-85% as compared with a 50% inhibition of wild-type
TH. The reduction in TH catalytic activity caused by ONOO
was significant for wild-type enzyme and for all mutants
(p < 0.05, Bonferroni's test).

View larger version (23K):
[in a new window]
Fig. 2.
Effects of
ONOO
on Tyr-to-Phe mutants of
TH. Wild-type (WT) TH or single, double, or triple
mutants (10 µM) of the indicated tyrosine residues were
treated with ONOO
(100 µM) and subjected to
immunoblotting with an antibody against nitrotyrosine (A),
immunoblotting with an antibody against TH (B), or
determinations of catalytic activity (C). Blots
in A and B were scanned with a CCD video camera,
and the relative pixel densities were used to normalize levels of
tyrosine nitration with the amount of TH protein in each lane. These
experiments were repeated five times, and produced the same results. TH
catalytic activity in C is expressed as percentage of the
untreated control for each mutant. Results represent means ± S.E.
of 4-6 independent experiments carried out in duplicate. Where
indicated (*), basal levels of TH activity were significantly lower
than wild-type enzyme in certain tyrosine mutants (p < 0.05, Bonferroni's test). The effect of ONOO
on the
activity of all forms of TH was significant (p < 0.01, Bonferroni's test).
on
the levels of enzyme activity and tyrosine nitration were determined.
The results are presented in Table I. All
Tyr-to-Phe mutants of TH retained catalytic activity, but some were
sensitive to substitution. For example, the basal activities of Y200F
and Y314F were about 40-45% of wild-type, and Y448F and Y463F
expressed higher levels of activity than wild-type TH (35-40%
increases). ONOO
treatment of each of these mutants
caused a significant reduction in their activities. Y214F was most
sensitive to inhibition, showing reductions in activity to 15% of
control after ONOO
treatment. Y225F and Y371F were
inhibited to 20% of control by ONOO
. The remaining
mutants were inhibited by ONOO
to about the same extent
as wild-type TH. Table I also shows that these same mutants were
tyrosine-nitrated to the same extent as wild-type enzyme.
Tyrosine-scanning mutagenesis of TH and the effects of ONOO
on catalytic activity and relative tyrosine nitration
on Cysteine Residues in Wild-type TH
and Phenylalanine Mutants of Tyrosines 423, 428, and
432--
Wild-type TH and the mutants of tyrosines 225, 423, 428, and
432 (single, double, and triple mutants) were treated with
ONOO
(100 µM) and probed with the highly
selective thiol reactants PMAB or BIAM, as described by Kim et
al. (29). These biotinylated reagents only label reduced
cysteines in proteins, and reductions in labeling are an index of
cysteine oxidation (29). Fig. 3 shows
that wild-type TH and each of the indicated tyrosine mutants were
extensively labeled by PMAB under control conditions. After treatment
of all proteins with ONOO
, the extent of PMAB labeling
was substantially reduced. Digital scans of the blot in Fig. 3 showed
that the relative reduction in labeling of each
ONOO
-treated mutant varied between 60 and 80% by
comparison with the respective controls. The same results were obtained
if labeling of these same mutants was carried out with BIAM (data not
shown). All remaining Tyr-to-Phe mutants of TH, listed in Table I, were also probed with PMAB after ONOO
treatment using the
ELISA format. The results with these mutants were the same as described
above, showing that ONOO
caused large reductions in PMAB
labeling, indicative of cysteine oxidation (data not shown).

View larger version (29K):
[in a new window]
Fig. 3.
Effects of
ONOO
on PMAB Labeling of Cysteine
Residues in TH. Wild-type TH or the indicated tyrosine mutants (10 µM) were treated with ONOO
(100 µM). Untreated enzyme served as controls for each form of
TH. Samples were labeled with the thiol-sensitive probe PMAB and
subjected to SDS-PAGE and blotting to nitrocellulose. Blots were
subsequently probed with avidin-linked horseradish peroxidase, and
PMAB-labeled proteins were visualized with enhanced chemiluminescence
as described under "Experimental Procedures." A, results
using single tyrosine mutants; B, results using double and
triple tyrosine mutants of TH. Each panel contains wild-type
(WT) TH as a control. The addition of ONOO
is
indicated above each panel (
, control; +,
ONOO
).
reduced cysteine labeling with PMAB, only results
with wild-type TH are presented. Fig. 4
shows that DTNB (500 µM) reduced TH activity to 20% of
control, and pCMB (500 µM) reduced enzyme activity to 50% of control. The effects of pCMB and DTNB on TH activity were significant (p < 0.01, Bonferroni's test). The
inset to Fig. 4 shows that concentrations of pCMB and DTBN
that inhibited TH catalytic activity reduced PMAB labeling of the
protein. Digital scans indicated that pCMB reduced PMAB labeling of TH
by 80%, whereas DTNB caused a 50% reduction in labeling.

View larger version (15K):
[in a new window]
Fig. 4.
Effects of sulfhydryl reagents on TH activity
and PMAB-mediated cysteine labeling. Wild-type TH was treated with
pCMB or DTNB (500 µM for each), and the effects on
catalytic activity were determined. Results are expressed as percentage
of control of untreated TH and represent means ± S.E. of six
independent experiments carried out in duplicate. The inset
presents the results of PMAB labeling of cysteine residues in TH after
treatment with pCMB or DTNB.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-induced
nitration of tyrosine residues in the enzyme (1, 5). This finding could
offer insight into early biochemical processes that contribute to
neuronal dopamine deficiencies. ONOO
-induced nitration of
TH and other proteins may be an early manifestation of oxidative stress
in dopamine neurons brought on by drugs or diseases that are associated
with toxicity and damage. The mechanism by which TH is inactivated by
ONOO
is not fully understood. Nitration of tyrosine
residues is but one element of the reactivity associated with
ONOO
. In fact, ONOO
is extremely reactive
with cysteine (32, 33) and has been shown to target this residue with
much higher probability than it nitrates tyrosines within the same
protein (34). ONOO
causes extensive oxidation of cysteine
residues in TH, and we have attributed inactivation of the enzyme to
sulfhydryl oxidation, not tyrosine nitration (3).
would not only contribute to a better understanding
of TH catalysis but could help identify site-specific posttranslational
modifications that are early markers of neuronal damage. This goal has
proved difficult with respect to TH. For example, Ara et al.
(1) concluded that Tyr225 was the site of
ONOO
-induced nitration in TH. More recently, this same
group concluded that Tyr423, not Tyr225, is the
site that mediates ONOO
-induced inactivation (5). A Y423F
mutant of TH was extensively nitrated by ONOO
, but,
paradoxically, catalytic activity was not reduced. We have used a
combination of MALDI-TOF mass spectrometry and tyrosine-scanning mutagenesis to identify the tyrosine residues in TH that are nitrated by ONOO
.
-induced
nitration was substantially reduced in each single mutant (30-60%
reductions). Second, all double mutants (i.e. Y423F,Y428F, Y423F,Y432F, and Y428F,Y432F) showed less nitration than the single mutants in response to ONOO
. The extent of reduction in
nitration of the single mutants was retained in the respective double
mutants, reaching levels of only 10-30% of control. Third, the triple
mutant was not nitrated by ONOO
. Thus, the findings with
site-directed mutagenesis are in agreement with those from analyses by
MALDI-TOF MS that TH is nitrated at as many as three tyrosines when
treated with a 10-fold excess of ONOO
. We could not find
any evidence that Tyr225 was a site of
ONOO
-induced nitration, despite the conclusions of Ara
et al. (1) that this residue represented the site in TH of
ONOO
-induced nitration.
, and it appeared that some mutants were actually
more sensitive to inhibition than wild-type enzyme. Taken together,
these data indicate that the progressive removal from TH of tyrosines
that are sites of nitration neither completely disrupts catalytic
function nor prevents enzyme inactivation by ONOO
. The
remaining 14 tyrosines in TH were mutated to phenylalanine individually
with the goal of identifying additional nitration sites that might not
be accounted for by MALDI-TOF MS (e.g. peptide fragments
that did not desorb from the MALDI plate). It was observed that almost
all single Tyr-to-Phe mutants of TH retained substantial levels of
catalytic activity, all were substrates for nitration by
ONOO
, and all were inhibited to similar extents by
treatment with ONOO
. The triple mutant, however, was not
nitrated, and in combination with the MALDI-TOF MS data, substantial
evidence is provided to conclude that TH is nitrated by
ONOO
at Tyr423, Tyr428, and
Tyr432.
inhibited TH tyrosine mutants
in the face of diminishing tyrosine nitration prompted consideration of
alternative mechanisms. Previous work from our laboratory showed that
ONOO
lowered the number of DTNB-reactive cysteine
residues in TH in parallel with losses in catalytic activity (3). These
results are consistent with ONOO
serving as a powerful
cysteine oxidant (33, 34). Nevertheless, Ishiropoulos and colleagues
(1, 5) could not find evidence of ONOO
-induced cysteine
modification in TH. We probed ONOO
-treated TH with the
thiol-reactive compounds PMAB and BIAM, reagents that are known to
react with reduced cysteines (29). We hypothesized that
ONOO
would reduce labeling if it oxidized cysteines in
TH. This is, in fact, what was observed. PMAB labeling of wild-type TH
and of all Tyr-to-Phe mutants was lowered substantially by comparison with that of untreated controls. While not quantitative, the results with PMAB agree with our previous results using DTNB titration of
reduced cysteines (3) and show that ONOO
reacts with
cysteine residues in the enzyme. TH was also sensitive to inhibition by
thiol-sensitive reagents pCMB and DNTB. These compounds, like
ONOO
, inhibited TH catalytic function and significantly
reduced PMAB labeling of the enzyme. Evidence from another line of
investigation establishes that TH activity can be disrupted when its
cysteines are modified. Dopamine-quinones inactivate TH by binding to
cysteine residues (21). Modification of cysteines by quinones was
substantiated by the loss of DTNB reactivity from TH and by the
appearance of cysteinyl-dopamine. The extent of cysteine modification
in TH was predictive of the losses in catalytic activity in these
studies (21). Therefore, TH is readily inhibited by various
thiol-reactive reagents, including ONOO
.
-helices that form a large hydrophobic pocket involved in pterin
cofactor binding (35, 38, 39), yet it tolerates mutagenesis to
phenylalanine very well. This is not that surprising when considering that this hydrophobic pocket accommodates numerous bulky substitutions at the C-6 position of the pterin cofactor (38, 39).
Tyr423 and Tyr428 lie within one of two loops,
the other of which is composed of residues 290-296, that reach
over the active site opening of the TH (37, 38). The conservative
substitution of these residues with phenylalanine, one at a time, has
little impact on TH activity. However, double mutations among these
tyrosines do lower catalytic activity slightly, and a triple mutant
expresses only 20% of the activity of wild-type enzyme. It is possible
that removal of the hydroxyl group from two of the tyrosine residues in
this loop changes its orientation with respect to the other loop,
hindering access of the substrates to the active site.
. Single, double, and triple tyrosine
mutants of TH retained catalytic function and were inhibited by
ONOO
, while showing little if any tyrosine nitration. In
the face of diminished levels of tyrosine nitration, cysteine
modification was apparent in all tyrosine mutants of TH after treatment
with ONOO
. Tyrosine nitration is neither necessary nor
sufficient to explain the inhibition of TH by ONOO
, and
evidence points increasingly to cysteines as determinants of TH
catalytic function and as targets for modification by reactive nitrogen
species like ONOO
.
![]()
FOOTNOTES
To whom correspondence should be addressed: 2125 Scott Hall,
540 E. Canfield, Wayne State University School of Medicine, Detroit, MI
48201. Tel./Fax: 313-577-9737; E-mail: donald.kuhn@wayne.edu.
![]()
ABBREVIATIONS
, peroxynitrite;
PEO, polyethylene
oxide;
DTNB, 5,5'-dithiobis-2-nitrobenzoic acid;
pCMB, p-chloromercuribenzoic acid, PMAB, PEO-maleimide-activated biotin;
BIAM, N-biotinoyl-N-(iodoacetyl)ethylene diamine;
HPLC, high performance liquid chromatography;
MALDI, matrix-assisted
laser desorption-ionization;
TOF, time-of-flight;
ELISA, enzyme-linked
immunosorbent assay;
MS, mass spectrometry.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Ara, J.,
Przedborski, S.,
Naini, A. B.,
Jackson-Lewis, V.,
Trifiletti, R. R.,
Horwitz, J.,
and Ischiropoulos, H.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
7659-7663 2.
Blum, D.,
Torch, S.,
Lambeng, N.,
Nissou, M.,
Benabid, A. L.,
Sadoul, R.,
and Verna, J. M.
(2001)
Prog. Neurobiol.
65,
135-172[CrossRef][Medline]
[Order article via Infotrieve] 3.
Kuhn, D. M.,
Aretha, C. W.,
and Geddes, T. J.
(1999)
J. Neurosci.
19,
10289-10294 4.
Ischiropoulos, H.,
Duran, D.,
and Horwitz, J.
(1995)
J. Neurochem.
65,
2366-2372[Medline]
[Order article via Infotrieve] 5.
Blanchard-Fillion, B.,
Souza, J. M.,
Friel, T.,
Jiang, G. C. T.,
Vrana, K.,
Sharov, V.,
Baron, L.,
Schoneich, C.,
Quijano, C.,
Alvarez, B.,
Radi, R.,
Przedborski, S.,
Fernado, G. S.,
Horwitz, J.,
and Ischiropoulos, H.
(2001)
J. Biol. Chem.
276,
46017-46023 6.
Groves, J. T.
(1999)
Curr. Opin. Chem. Biol.
3,
226-235[CrossRef][Medline]
[Order article via Infotrieve] 7.
Ducrocq, C.,
Blanchard, B.,
Pignatelli, B.,
and Ohshima, H.
(1999)
Cell Mol. Life Sci.
55,
1068-1077[CrossRef][Medline]
[Order article via Infotrieve] 8.
Squadrito, G. L.,
and Pryor, W. A.
(1998)
Free Radic. Biol. Med.
25,
392-403[CrossRef][Medline]
[Order article via Infotrieve] 9.
Lymar, S. V.,
and Hurst, J. K.
(1998)
Chem. Res. Toxicol.
11,
714-715[CrossRef][Medline]
[Order article via Infotrieve] 10.
Beckman, J. S.,
and Koppenol, W. H.
(1996)
Am. J. Physiol.
271,
C1424-C1437 11.
Crow, J. P.,
and Beckman, J. S.
(1995)
Adv. Pharmacol.
34,
17-43 12.
Ischiropoulos, H.,
and al-Mehdi, A. B.
(1995)
FEBS Lett.
364,
279-282[CrossRef][Medline]
[Order article via Infotrieve] 13.
Crow, J. P.,
and Ischiropoulos, H.
(1996)
Methods Enzymol.
269,
185-194[Medline]
[Order article via Infotrieve] 14.
Good, P. F.,
Werner, P.,
Hsu, A.,
Olanow, C. W.,
and Perl, D. P.
(1996)
Am. J. Pathol.
149,
21-28[Abstract] 15.
Lyras, L.,
Perry, R. H.,
Perry, E. K.,
Ince, P. G.,
Jenner, A.,
Jenner, P.,
and Halliwell, B.
(1998)
J. Neurochem.
71,
302-312[Medline]
[Order article via Infotrieve] 16.
Giasson, B. I.,
Duda, J. E.,
Murray, I. V.,
Chen, Q.,
Souza, J. M.,
Hurtig, H. I.,
Ischiropoulos, H.,
Trojanowski, J. Q.,
and Lee, V. M.
(2000)
Science
290,
985-989 17.
Souza, J. M.,
Giasson, B. I.,
Chen, Q.,
Lee, V. M.,
and Ischiropoulos, H.
(2000)
J. Biol. Chem.
275,
18344-18349 18.
Przedborski, S.,
Chen, Q.,
Vila, M.,
Giasson, B. I.,
Djaldatti, R.,
Vukosavic, S.,
Souza, J. M.,
Jackson-Lewis, V.,
Lee, V. M.,
and Ischiropoulos, H.
(2001)
J. Neurochem.
76,
637-640[CrossRef][Medline]
[Order article via Infotrieve] 19.
Good, P. F.,
Hsu, A.,
Werner, P.,
Perl, D. P.,
and Olanow, C. W.
(1998)
J. Neuropathol. Exp. Neurol.
57,
338-342[Medline]
[Order article via Infotrieve] 20.
Torreilles, F.,
Salman-Tabcheh, S.,
Guerin, M.,
and Torreilles, J.
(1999)
Brain Res. Brain Res. Rev.
30,
153-163[CrossRef][Medline]
[Order article via Infotrieve] 21.
Kuhn, D. M.,
Arthur, R. E., Jr.,
Thomas, D. M.,
and Elferink, L. A.
(1999)
J. Neurochem.
73,
1309-1317[CrossRef][Medline]
[Order article via Infotrieve] 22.
Grima, B.,
Lamouroux, A.,
Blanot, F.,
Biguet, N. F.,
and Mallet, J.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
617-621 23.
Horton, R. M., Ho, S. N.,
Pullen, J. K.,
Hunt, H. D.,
Cai, Z.,
and Pease, L. R.
(1993)
Methods Enzymol.
217,
270-279[Medline]
[Order article via Infotrieve] 24.
Beckman, J. S.,
Chen, J.,
Ischiropoulos, H.,
and Crow, J. P.
(1994)
Methods Enzymol.
233,
229-240[Medline]
[Order article via Infotrieve] 25.
Lerner, P.,
Nose, P.,
Ames, M. M.,
and Lovenberg, W.
(1978)
Neurochem. Res.
3,
641-651[CrossRef][Medline]
[Order article via Infotrieve] 26.
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve] 27.
Cadene, M.,
and Chait, B. T.
(2000)
Anal. Chem.
72,
5655-5658[Medline]
[Order article via Infotrieve] 28.
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve] 29.
Kim, J. R.,
Yoon, H. W.,
Kwon, K. S.,
Lee, S. R.,
and Rhee, S. G.
(2000)
Anal. Biochem.
283,
214-221[CrossRef][Medline]
[Order article via Infotrieve] 30.
Sarver, A.,
Scheffler, N. K.,
Shetlar, M. D.,
and Gibson, B. W.
(2001)
J. Am. Soc. Mass Spectrom.
12,
439-448[CrossRef][Medline]
[Order article via Infotrieve] 31.
van Iwaarden, P. R.,
Driessen, A. J.,
and Konings, W. N.
(1992)
Biochim. Biophys. Acta
1113,
161-170[Medline]
[Order article via Infotrieve] 32.
Radi, R.,
Beckman, J. S.,
Bush, K. M.,
and Freeman, B. A.
(1991)
J. Biol. Chem.
266,
4244-4250 33.
Quijano, C.,
Alvarez, B.,
Gatti, R. M.,
Augusto, O.,
and Radi, R.
(1997)
Biochem. J.
322,
167-173 34.
Alvarez, B.,
Ferrer-Sueta, G.,
Freeman, B. A.,
and Radi, R.
(1999)
J. Biol. Chem.
274,
842-848 35.
Daubner, S. C.,
and Fitzpatrick, P. F.
(1998)
Biochemistry
37,
16440-16444[Medline]
[Order article via Infotrieve] 36.
Erlandsen, H.,
Bjorgo, E.,
Flatmark, T.,
and Stevens, R. C.
(2000)
Biochemistry
39,
2208-2217[CrossRef][Medline]
[Order article via Infotrieve] 37.
Goodwill, K. E.,
Sabatier, C.,
Marks, C.,
Raag, R.,
Fitzpatrick, P. F.,
and Stevens, R. C.
(1997)
Nat. Struct. Biol.
4,
578-585[CrossRef][Medline]
[Order article via Infotrieve] 38.
Goodwill, K. E.,
Sabatier, C.,
and Stevens, R. C.
(1998)
Biochemistry
37,
13437-13445[CrossRef][Medline]
[Order article via Infotrieve] 39.
Almas, B.,
Toska, K.,
Teigen, K.,
Groehn, V.,
Pfleiderer, W.,
Martinez, A.,
Flatmark, T.,
and Haavik, J.
(2000)
Biochemistry
39,
13676-13686[Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. N. MacRitchie, A. A. Gardner, S. M. Prescott, and D. M. Stafforini Molecular basis for susceptibility of plasma platelet-activating factor acetylhydrolase to oxidative inactivation FASEB J, April 1, 2007; 21(4): 1164 - 1176. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fujigaki, K. Saito, F. Lin, S. Fujigaki, K. Takahashi, B. M. Martin, C. Y. Chen, J. Masuda, J. Kowalak, O. Takikawa, et al. Nitration and Inactivation of IDO by Peroxynitrite J. Immunol., January 1, 2006; 176(1): 372 - 379. [Abstract] [Full Text] [PDF] |
||||